Repligen Corp (NASDAQ:RGEN)

32.75
Delayed Data
As of Feb 16
 -0.11 / -0.33%
Today’s Change
29.56
Today|||52-Week Range
46.81
-9.73%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close32.86
Today’s open32.76
Day’s range32.71 - 33.38
Volume154,769
Average volume (3 months)342,864
Market cap$1.4B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+40.06%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+25.14%
P/E ratio57.5
Price/Sales10.05
Price/Book6.57

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...+0.20+1.03%
ARRYArray Biopharma Inc-0.27-1.57%
LXRXLexicon Pharmaceutic...-0.07-0.88%
CBMCambrex Corp-0.10-0.19%
Data as of 4:02pm ET, 02/16/2018

Financials

Next reporting dateFebruary 21, 2018
EPS forecast (this quarter)$0.12
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts